Position in MYGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$419,713
+$103,629 QoQ
Shares Held
73,505
+4.6% QoQ
Ownership
0.077%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#76
of 196 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MYGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Creative Planning holds $272,210,544 across 30 Diagnostics & Research names. MYGN ranks #24 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
137,468 | $68,920,956 | |
| 2 | DHR |
Danaher Corp /De/
|
198,583 | $37,826,089 | |
| 3 | A |
Agilent Technologies, Inc.
|
188,942 | $25,097,165 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
43,512 | $22,906,457 | |
| 5 | GH |
Guardant Health, Inc.
|
107,052 | $16,061,011 | |
| 6 | WAT |
Waters Corp /De/
|
38,901 | $14,589,430 | |
| 7 | ILMN |
Illumina, Inc.
|
70,361 | $12,371,573 | |
| 8 | NTRA |
Natera, Inc.
|
40,849 | $11,088,460 |
All Filings in MYGN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $419,713 | 73,505 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $316,084 | 70,241 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $453,488 | 73,738 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $561,893 | 77,717 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $180,130 | 33,923 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $213,935 | 24,119 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $945 | 69 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $272,502 | 9,949 | Shares | Defined | 2024-10-11 | |
| 2024-06-30 | $221,533 | 9,057 | Shares | Defined | 2024-08-15 | |
| No filing history on record for this holder in this stock. | ||||||